Last Updated: May 10, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2008045410


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2008045410

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Sep 26, 2027 Cipla ARGATROBAN IN SODIUM CHLORIDE argatroban
⤷  Start Trial Sep 26, 2027 Cipla ARGATROBAN IN SODIUM CHLORIDE argatroban
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Key insights for pharmaceutical patentability - World Intellectual Property Organization (WIPO) patent WO2008045410

Last updated: April 25, 2026

WO2008045410 (WIPO): Scope, Claims, and Patent Landscape

What is WO2008045410 and what does it claim?

WO2008045410 is a WIPO published patent application (PCT) first made public in 2008, under the WO publication family. Without the underlying publication text, claim set, and bibliographic details, a complete and accurate scope and claims analysis cannot be produced.

What is the legal scope of protection under the claims?

A claim-by-claim construction requires the exact independent and dependent claim language, including:

  • the claimed therapeutic indication(s)
  • compound/formula definitions
  • structural and functional limitations
  • dose/regimen language
  • administration route language
  • markers/biomarkers and patient selection criteria
  • manufacturing process steps (if any)
  • method-of-treatment vs composition vs use claim formats
  • claim dependencies and claim numbering

A legal scope summary also requires:

  • claim breadth indicators (genus vs species coverage)
  • explicit exclusions
  • defined terms and preferred embodiments that appear in claims
  • claim interpretation dependencies (for example, definitions incorporated from description)

What does the patent landscape look like around WO2008045410?

A patent landscape that is decision-grade for investment or R&D requires at minimum:

  • all INPADOC family members and their jurisdictions (US, EP, JP, KR, CN, etc.)
  • priority dates, filing dates, and publication numbers per country
  • claim status by jurisdiction (granted, pending, refused, lapsed)
  • key citations and prosecution history (where available) that establish novelty boundaries
  • intersecting competitor portfolios and likely design-around routes

Without the WO publication record, family mapping, and claim text, any landscape would be incomplete or potentially inaccurate.


Key Takeaways

  • A complete scope and claims analysis for WO2008045410 is not possible without the WO publication text and claim set.
  • A decision-grade patent landscape requires family mapping and jurisdictional status, which cannot be derived from the WO identifier alone.
  • No actionable, claim-accurate deliverable can be produced under these constraints.

FAQs

1) Can you summarize WO2008045410 scope without the claim text?
No. Claim scope depends on the exact wording of independent and dependent claims.

2) Does WO2008045410 likely cover a compound, a formulation, or a method?
The coverage type cannot be determined without the published description and claims.

3) Can you map a full patent landscape without knowing the family members?
No. Competitor overlap and freedom-to-operate require family and jurisdictional data.

4) Can prosecution outcomes change how claims are construed?
Yes, but the outcomes require access to file history or granted claim sets.

5) What would a complete landscape include?
Family structure, claim status, key cited prior art, and competitor cluster mapping, all derived from the publication and legal status records.


References

[1] WIPO. WO2008045410. (Patent publication). World Intellectual Property Organization.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.